Skip to content
Health Science Institute
  • About Us
  • News & Trends
  • Mental Health
    • Stress
    • Depressive States
    • Sleep
    • Anxious thoughts
    • Mood
  • Family Health
    • Child Health
    • Men’s Health
    • Senior Health
    • Women’s Health
  • Problems
    • Autoimmune Disorders
    • Chronic Pain
    • Digestion
    • Energy
    • Fatigue
    • Heart Health
    • Inflammation
    • Post-Viral Fatigue
  • Tech
    • AI in Healthcare
    • Biotechnology in Medicine
    • Digital Therapeutics
    • Wearable Health Tech

obesity drugs WHO

Home » obesity drugs WHO
No Obesity Drugs in WHO Essential Medicines List
Posted inBiotechnology in Medicine Health Tech

No Obesity Drugs in WHO Essential Medicines List

Key Points WHO excluded all obesity drugs, including semaglutide (Wegovy), from its 2023 Essential Medicines List (EML). The decision…
Posted by By Dr Anne Therese Bernadette Laudato, MD 2 Comments0 Shares
Search Articles
Recent Post
  • I Used a Vagus Nerve Device for 30 Days to See If It Could Help With My Post-Viral Fatigue… Here’s What Happened
  • ICU Nurse: I Thought I Was Just Exhausted – Until I Realised My Nervous System Was Stuck in Survival Mode
  • I Used a Vagus Nerve Device for 30 Days to See If It Could Help With My Restless Sleep… Here’s What Happened
  • I Used a Vagus Nerve Device for 30 Days to See If It Could Help With My Constant Tiredness… Here’s What Happened
  • I Used a Vagus Nerve Device for 30 Days to See If It Could Help With My Bloated Gut… Here’s What Happened

Limited-time offers in health tech​​

Nurosym

Save €70 from the most studies VNS system for a limited time

Take vagus nerve impairment assessment, get 10% off.

Ends 20 June, 2026

Learn More
Health Science Institute

© 2026 — Health Science Institute. All rights reserved.
The services, content, and products offered on our website are intended for informational purposes only. Health Science Institute does not offer medical advice, diagnoses, or treatment recommendations.

Menu
  • About Us
  • Contact Us
  • Newsletter
  • Terms and Conditions
Menu
  • Privacy Policy
  • Content Integrity
  • Editorial Process
Scroll to Top
en_USEnglish
de_DEGerman fr_FRFrench es_ESSpanish sv_SESwedish en_USEnglish